TTLL4 and hepatocellular carcinoma: The overexpression of TTLL4 potentially activates the PI3K–AKT–MDM2 pathway by regulating PI3K expression through protein polyglutamylation, thereby enhancing the malignant biological behaviors of HCC, including proliferation, migration, tumorigenesis, and metastatic capabilities.